Table 3.

In vitro susceptibilities of Candida bloodstream isolates to five antifungals, Iceland, 2000 to 2011

Species	Antifungal agent (no. of isolates tested)	MIC (μg/ml)
		Range	50%	90%
C. albicans	Amphotericin B (124)	0.002–0.50	0.125	0.25
	Fluconazole (124)	0.023–1.0	0.19	0.5
	Itraconazole (116)	0.004–0.32	0.032	0.125
	Voriconazole (64)	0.002–0.38	0.008	0.016
	Caspofungin (41)	0.023–0.38	0.19	0.25
C. glabrata	Amphotericin B (36)	0.002–1.0	0.38	0.75
	Fluconazole (36)	0.023–48	1.5	16
	Itraconazole (35)	0.064–32	0.75	32
	Voriconazole (22)	0.002–1.5	0.064	0.75
	Caspofungin (14)	0.064–0.38	0.19	0.38
C. tropicalis	Amphotericin B (28)	0.002–0.75	0.125	0.50
	Fluconazole (28)	0.125–8	0.38	1.0
	Itraconazole (27)	0.003–1.5	0.016	0.064
	Voriconazole (16)	0.006–0.5	0.032	0.094
	Caspofungin (7)	0.064–0.75	0.19	0.75
C. dubliniensis	Amphotericin B (12)	0.012–0.38	0.064	0.125
	Fluconazole (12)	0.047–2	0.125	0.38
	Itraconazole (12)	0.003–0.50	0.016	0.38
	Voriconazole (6)	0.002–0.012	0.006	0.012
	Caspofungin (3)	0.25–0.50	0.38	0.50
C. parapsilosis	Amphotericin B (11)	0.125–0.38	0.19	0.25
	Fluconazole (11)	0.047–1.5	0.25	1.0
	Itraconazole (11)	0.006–0.094	0.023	0.064
	Voriconazole (5)	0.003–0.016	0.004	0.016
	Caspofungin (5)	1.0–2	1.5	2